Question 1

Does Squarepoint Ops own TSHA stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Squarepoint Ops holds 569,269 shares of TSHA (Taysha Gene Therapies), worth $3.9M.

Question 2

How many shares of TSHA does Squarepoint Ops own?

Accepted Answer

As of its Q2 2026 13F, Squarepoint Ops holds 569,269 shares of TSHA (Taysha Gene Therapies).

Question 3

What is Squarepoint Ops' TSHA position worth?

Accepted Answer

As of its Q2 2026 13F, Squarepoint Ops' TSHA position is worth $3.9M.

Question 4

Is Squarepoint Ops buying or selling TSHA?

Accepted Answer

In Q2 2026, Squarepoint Ops increased its TSHA position by 158,987 shares (+38.8%).

Question 5

When did Squarepoint Ops first buy TSHA?

Accepted Answer

Squarepoint Ops first reported TSHA in its Q4 2021 13F and has listed it in 13 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	569,269	+38.8%	$3.9M	0.0%	$6.81	35
2026-Q1	Decreased	410,282	-13.0%	$1.8M	0.0%	$4.53	0
2025-Q4	Increased	471,577	+137.8%	$2.6M	0.0%	$5.66	42
2025-Q3	Increased	198,352	+97.9%	$648,611	0.0%	$3.16	39
2025-Q2	New	100,226	—	$231,522	0.0%	$2.38	32
2025-Q1	Exited	0	-100.0%	$0	0.0%	$1.93	0
2024-Q4	Increased	211,842	+105.4%	$366,487	0.0%	$1.73	38
2024-Q3	Increased	103,123	+28.5%	$207,277	0.0%	$2.07	29